Learning Objective
By the end of this section, students should be able to classify sympathomimetic drugs, identify their receptor selectivity, predict their hemodynamic effects, and select the appropriate clinical application in common Step 1 scenarios.
Sympathomimetic Drugs
Sympathomimetics are agents that stimulate adrenergic receptors either directly or indirectly, producing cardiovascular, pulmonary, and metabolic effects. Their clinical use depends on receptor selectivity, dose, and route of administration.
Direct Sympathomimetics
β₂-Selective Agonists
Albuterol, Salmeterol, Terbutaline (β₂ > β₁)
- Hemodynamic effects: Minimal ↑ HR
- Primary actions: Bronchodilation, uterine relaxation
- Clinical uses:
- Albuterol: Acute asthma/COPD exacerbations
- Salmeterol: Long-term (maintenance) asthma/COPD
- Terbutaline: Acute bronchospasm, tocolysis
β₁-Selective Agonist
Dobutamine (β₁ > β₂)
- Hemodynamic effects: ↑ HR, ↑ contractility, ↑ cardiac output; BP unchanged or ↓
- Clinical uses:
- Cardiac stress testing
- Acute decompensated heart failure with cardiogenic shock
- Key concept: Pure inotrope
Mixed Dopamine Receptor Agonist
Dopamine (D₁ = D₂ > β > α)
- Dose-dependent effects:
- Low dose: Renal vasodilation (D₁)
- Medium dose: ↑ HR, ↑ CO (β₁)
- High dose: Vasoconstriction, ↑ BP (α₁)
- Clinical uses: Shock, unstable bradycardia
Mixed α and β Agonists
Epinephrine (β > α)
- Hemodynamic effects: ↑ HR, ↑ CO; ↑ BP at high doses
- Clinical uses:
- Anaphylaxis
- Asthma
- Shock
- Key concept: Stronger β₂ effect than norepinephrine
Norepinephrine (α₁ > α₂ > β₁)
- Hemodynamic effects: ↑ BP, minimal or reflex ↓ HR, variable CO
- Clinical uses: Septic shock, severe hypotension
Selective Vasodilators
Fenoldopam (D₁ agonist)
- Hemodynamic effects: Vasodilation → ↓ BP, ↑ HR, ↑ CO
- Clinical uses: Hypertensive emergencies
- Additional effects: Natriuresis
- Adverse effects: Headache, flushing, hypotension
Pure β Agonist
Isoproterenol (β₁ = β₂)
- Hemodynamic effects: ↓ BP (vasodilation), ↑ HR, ↑ CO
- Clinical uses: Electrophysiologic testing for arrhythmias
- Note: No α activity → may worsen ischemia
α₁-Selective Agonists
Phenylephrine (α₁ > α₂)
- Hemodynamic effects: ↑ BP, reflex ↓ HR, ↓ or unchanged CO
- Clinical uses:
- Hypotension
- Nasal decongestion
- Mydriasis
- Ischemic priapism
Midodrine (α₁)
- Hemodynamic effects: ↑ BP, ↓ HR
- Clinical uses: Orthostatic hypotension
- Caution: Supine hypertension
β₃-Selective Agonist
Mirabegron (β₃)
- Primary effect: Bladder relaxation
- Clinical use: Overactive bladder
- Mnemonic: “Mirab3gron”
Indirect Sympathomimetics
These agents increase endogenous catecholamines by promoting release or inhibiting reuptake.
Amphetamine
- Mechanism: Increases release + inhibits reuptake of catecholamines
- Clinical uses: ADHD, narcolepsy, obesity
Cocaine
- Mechanism: Reuptake inhibition of NE, dopamine, serotonin
- Effects: Vasoconstriction, local anesthesia
- Key warning: Avoid β-blockers → unopposed α₁ stimulation
- Special use: Produces mydriasis in intact sympathetic innervation (Horner syndrome testing)
Ephedrine / Pseudoephedrine
- Mechanism: Releases stored catecholamines
- Clinical uses:
- Nasal decongestion
- Hypotension
- Urinary incontinence








